Enterprise Value
178.1M
Cash
171.7M
Avg Qtr Burn
-19.85M
Short % of Float
10.58%
Insider Ownership
0.88%
Institutional Own.
-
Qtr Updated
01/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sebetralstat (KVD900) (film coated) Details Hereditary angioedema , Rare diseases, Rare genetic disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
KVD001 (IVT) Details DME (Diabetic Macular Edema) | Phase 2 Update | |
KVD824 (plasma kallikrein enzyme inhibitor) Details Hereditary angioedema , Rare diseases, Rare genetic disease | Failed Discontinued |